159 related articles for article (PubMed ID: 36621346)
1. Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria.
Lewis E; Lee H; Fine N; Miller R; Hahn C; Tay J; Chhibber S; Mahe E; Jimenez-Zepeda VH
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):211-217. PubMed ID: 36621346
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Phull P; Sanchorawala V; Connors LH; Doros G; Ruberg FL; Berk JL; Sarosiek S
Amyloid; 2018 Mar; 25(1):62-67. PubMed ID: 29424556
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
Lu H; Zhang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
[TBL] [Abstract][Full Text] [Related]
4. Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report.
Haga T; Okumura T; Harada Y; Hiraiwa H; Morimoto R; Kaneko S; Kato N; Shinoda M; Murohara T
Egypt Heart J; 2024 Jun; 76(1):74. PubMed ID: 38856864
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
7. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
8. Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Sigurbergsdóttir AÝ; Rögnvaldsson S; Thorsteinsdóttir S; Sverrisdóttir I; Sigurðardóttir GÁ; Viðarsson B; Önundarson PT; Agnarsson BA; Sigurðardóttir M; Þorsteinsdóttir I; Ólafsson Í; Þórðardóttir ÁR; Gíslason GK; Ólafsson A; Hultcrantz M; Durie BGM; Harding S; Landgren O; Löve TJ; Kristinsson SY
Haematologica; 2023 Dec; 108(12):3392-3398. PubMed ID: 37439374
[TBL] [Abstract][Full Text] [Related]
9. Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.
Weiss BM; Minter A; Abadie J; Howard R; Ascencao J; Schechter GP; Kuehl M; Landgren O
Am J Hematol; 2011 Jun; 86(6):475-8. PubMed ID: 21544856
[TBL] [Abstract][Full Text] [Related]
10. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
11. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
12. Use of the Current Standard of Practice Serum Free Light Chains (sFLC) Reference Interval Puts Black Patients at 5 Times Higher Odds for Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
Azimi V; Fiala MA; Zaydman MA
Clin Chem; 2023 Sep; 69(9):1084-1086. PubMed ID: 37366327
[No Abstract] [Full Text] [Related]
13. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
Junejo S; Ali Y; Singh Lubana S; Tuli SS
Am J Case Rep; 2017 Nov; 18():1247-1250. PubMed ID: 29176541
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
Rognvaldsson S; Eythorsson E; Thorsteinsdottir S; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdóttir I; Olafsson I; Runolfsdottir HL; Helgason D; Emilsdottir AR; Agustsson AS; Bjornsson AH; Kristjansdottir G; Thordardottir AR; Indridason OS; Jonsson A; Gislason GK; Olafsson A; Steingrimsdottir H; Kampanis P; Hultcrantz M; Durie BGM; Harding S; Landgren O; Palsson R; Love TJ; Kristinsson SY
Blood Cancer J; 2021 Dec; 11(12):191. PubMed ID: 34853309
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and progression risk factors for patients with monoclonal gammopathy of undetermined significance].
Guan A; Shen KN; Zhang L; Cao XX; Su W; Zhou DB; Li J
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):137-140. PubMed ID: 36948868
[No Abstract] [Full Text] [Related]
18. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
[TBL] [Abstract][Full Text] [Related]
19. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Rauf MU; Hawkins PN; Cappelli F; Perfetto F; Zampieri M; Argiro A; Petrie A; Law S; Porcari A; Razvi Y; Bomsztyk J; Ravichandran S; Ioannou A; Patel R; Starr N; Hutt DF; Mahmood S; Wisniowski B; Martinez-Naharro A; Venneri L; Whelan C; Roczenio D; Gilbertson J; Lachmann HJ; Wechalekar AD; Rapezzi C; Serenelli M; Massa P; Caponetti AG; Ponziani A; Accietto A; Giovannetti A; Saturi G; Sguazzotti M; Gagliardi C; Biagini E; Longhi S; Fontana M; Gillmore JD
Eur Heart J; 2023 Jun; 44(24):2187-2198. PubMed ID: 36946431
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.
Cicero KI; Joffe M; Patel M; Chiuzan C; Pentz A; Ruff P; Lentzsch S; Leng S; Jacobson JS; Rebbeck TR; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2192-2198. PubMed ID: 36126958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
